Company Name: |
ChemStrong Scientific Co.,Ltd
|
Tel: |
0755-0755-66853366 13670046396 |
Email: |
sales@chem-strong.com |
Products Intro: |
Product Name:Rivaroxaban Impurity 11 CAS:1424944-35-3 Purity:95% HPLC Package:10mg;25mg;50mg;100mg
|
Company Name: |
Nanjing XiZe Biotechnology CO., Ltd.
|
Tel: |
025-58362220 15250997978 |
Email: |
1511893459@qq.com |
Products Intro: |
Product Name:Rivaroxaban Impurity 93 Purity:95% HPLC Package:10mg;25mg;50mg;100mg;250mg;500mg;1g
|
Company Name: |
Shanghai Xiang Xin Industrial Co., Ltd.
|
Tel: |
021-50211651 13651607026 |
Email: |
sales@xxgmpharm.com |
Products Intro: |
Product Name:Rivaroxaban Impurity CAS:1424944-35-3 Package:25mg/;50mg/;100mg/
|
|
| Rivaroxaban Impurity 93 Basic information |
Product Name: | Rivaroxaban Impurity 93 | Synonyms: | Rivaroxaban Impurity 14/2-[[(5R)-2-Oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-5-oxazolidinyl]methyl]-1H-isoindole-1,3(2H)-dione;Rivaroxaban 30;1H-Isoindole-1,3(2H)-dione, 2-[[(5R)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-5-oxazolidinyl]methyl]-;2-{2-Oxo-3-[4-(3-oxo-morpholin-4-yl)-phenyl]-oxazolidin-5-ylmethyl}-isoindole-1,3-dione;Rivaroxaban Impurity RC50;(R)-2-((2-oxo-3-(4-(3-oxomorpholino)phenyl)oxazolidin-5-yl)methyl)isoindoline-1,3-dione? (Rivaroxaban Impurity) | CAS: | 1424944-35-3 | MF: | C22H19N3O6 | MW: | 421.4 | EINECS: | | Product Categories: | | Mol File: | 1424944-35-3.mol | |
| Rivaroxaban Impurity 93 Chemical Properties |
Boiling point | 702.9±55.0 °C(Predicted) | density | 1.465±0.06 g/cm3(Predicted) | solubility | Acetonitrile (Slightly), DMSO (Slightly), Ethyl Acetate (Slightly, Heated) | pka | 0.99±0.20(Predicted) | form | Solid | color | White to Off-White |
| Rivaroxaban Impurity 93 Usage And Synthesis |
Uses | 2-[[(5R)-2-Oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-5-oxazolidinyl]methyl]-1H-isoindole-1,3(2H)-dione is an intermediate in the synthesis of ent-Rivaroxaban (R538005), the R-isomer of Rivaroxaban (R538000), which is a novel antithrombotic agent. |
| Rivaroxaban Impurity 93 Preparation Products And Raw materials |
|